“…An important development is the systematic decrease of particle size, resulting in nanogels with sizes in the lower nanometre range [10], which seems to convey to MIP's properties closer to those of biological antibodies, such as a quasi solubility, very few, or even one, binding site per particle, and a more homogeneous affinity distribution, which can be even further improved by fractioning the particles by affinity chromatography [11]. Resmini and colleagues [12] have shown that these particles, when imprinted with a transition state analogue, can be efficient enzyme mimics. Others have worked on improving the compatibility of MIPs with aqueous solvents, by using monomers that interact more strongly with the molecular template [13].…”